Fig 2.
Ratio of the cumulative hazard for cancer mortality to all-cause mortality [ω(ΛCSM /ΛACM)] as a function of the normalized generalized competing event risk score versus normalized cancer mortality risk score versus normalized all-cause mortality risk score for (A-C) prostate cancer, (D-F) head and neck cancer, and (G-I) breast cancer. ω is calculated at 10 years for prostate cancer and 5 years for head and neck and breast cancer.